In particular, we observed that BCMA, a target antigen in MM cells and currently being tested for CAR immunotherapy [84], is transferred to CB-NK and to neighboring MM cells (Personal Communication: [88]). This evidence concerns the gene TNFRSF17 and Miyoshi myopathy.